Impact of pre‐therapy glioblastoma multiforme microenvironment on clinical response to autologous CMV‐specific T‐cell therapy
David Walker(St. Jude Children's Research Hospital), Rajiv Khanna(QIMR Berghofer Medical Research Institute), Reshma Shakya(QIMR Berghofer Medical Research Institute), John M. Nicholls(University of Hong Kong), Beth Morrison(Queensland Emergency Medicine Research Foundation), Katherine Matthews, Michelle A. Neller(QIMR Berghofer Medical Research Institute), Corey Smith(QIMR Berghofer Medical Research Institute)
Cited by 12
Related Papers
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
|The Journal of Experimental Medicine|1992|391
Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
|Proceedings of the National Academy of Sciences|1999|332
An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.
|The Journal of Experimental Medicine|1994|276
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
|Cancer Discovery|2019|272
Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.
|Journal of Clinical Pathology|1984|261